ANI Pharmaceuticals, Inc. (ANIP)
71.47
+0.41
(+0.58%)
USD |
NASDAQ |
Nov 13, 16:00
71.47
0.00 (0.00%)
After-Hours: 19:59
ANI Pharmaceuticals Total Liabilities (Quarterly) : 930.55M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 930.55M |
| June 30, 2026 | 896.90M |
| March 31, 2026 | 859.67M |
| December 31, 2025 | 899.65M |
| September 30, 2025 | 902.34M |
| June 30, 2025 | 906.24M |
| March 31, 2025 | 873.81M |
| December 31, 2024 | 880.79M |
| September 30, 2024 | 881.43M |
| June 30, 2024 | 464.99M |
| March 31, 2024 | 462.56M |
| December 31, 2023 | 471.67M |
| September 30, 2023 | 460.05M |
| June 30, 2023 | 424.87M |
| March 31, 2023 | 425.74M |
| December 31, 2022 | 431.62M |
| September 30, 2022 | 402.44M |
| June 30, 2022 | 414.38M |
| March 31, 2022 | 398.75M |
| December 31, 2021 | 422.35M |
| September 30, 2021 | 279.05M |
| June 30, 2021 | 288.24M |
| March 31, 2021 | 260.13M |
| December 31, 2020 | 273.08M |
| September 30, 2020 | 267.48M |
| Date | Value |
|---|---|
| June 30, 2020 | 274.05M |
| March 31, 2020 | 281.06M |
| December 31, 2019 | 251.05M |
| September 30, 2019 | 243.64M |
| June 30, 2019 | 239.25M |
| March 31, 2019 | 234.68M |
| December 31, 2018 | 233.34M |
| September 30, 2018 | 246.98M |
| June 30, 2018 | 239.07M |
| March 31, 2018 | 238.38M |
| December 31, 2017 | 237.38M |
| September 30, 2017 | 187.67M |
| June 30, 2017 | 182.67M |
| March 31, 2017 | 184.93M |
| December 31, 2016 | 153.22M |
| September 30, 2016 | 150.55M |
| June 30, 2016 | 144.22M |
| March 31, 2016 | 131.41M |
| December 31, 2015 | 125.18M |
| September 30, 2015 | 127.38M |
| June 30, 2015 | 120.62M |
| March 31, 2015 | 121.24M |
| December 31, 2014 | 123.92M |
| September 30, 2014 | 8.145M |
| June 30, 2014 | 3.828M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 107.80B |
| Supernus Pharmaceuticals, Inc. | 335.21M |
| Ocular Therapeutix, Inc. | 164.70M |
| Corcept Therapeutics, Inc. | 200.29M |
| Veru, Inc. | 8.651M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.568B |
| Shareholders Equity (Quarterly) | 637.11M |
| Debt to Equity Ratio | 0.9531 |
| Current Ratio | 2.746 |
| Net Debt Paydown Yield | 0.47% |